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Abstract
Recent studies have indicated that the choice of lineage of neural progenitor cells is determined, at least in part, by
environmental factors, such as neurotrophic factors. Despite extensive studies using exogenous neurotrophic factors, the
effect of endogenous neurotrophic factors on the differentiation of progenitor cells remains obscure. Here we show that
embryonic spinal cord derived-progenitor cells express both ciliary neurotrophic factor (CNTF) and brain-derived
neurotrophic factor (BDNF) mRNA before differentiation. BDNF gene expression significantly decreases with their
differentiation into the specific lineage, whereas CNTF gene expression significantly increases. The temporal pattern of
neurotrophic factor gene expression in progenitor cells is similar to that of the spinal cord during postnatal development.
Approximately 50% of spinal progenitor cells differentiated into astrocytes. To determine the effect of endogenous CNTF on
their differentiation, we neutralized endogenous CNTF by administration of its polyclonal antibody. Neutralization of
endogenous CNTF inhibited the differentiation of progenitor cells into astrocytes, but did not affect the numbers of neurons
or oligodendrocytes. Furthermore, to mimic the profile of neurotrophic factors in the spinal cord during embryonic
development, we applied BDNF or neurotrophin (NT)-3 exogenously in combination with the anti-CNTF antibody. The
exogenous application of BDNF or NT-3 promoted the differentiation of these cells into neurons or oligodendrocytes,
respectively. These findings suggest that endogenous CNTF and exogenous BDNF and NT-3 play roles in the differentiation of
embryonic spinal cord derived progenitor cells into astrocytes, neurons and oligodendrocytes, respectively.
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Introduction
Neural stem/progenitor cells are an ideal source of tissue for
neural transplantation, since these cells can be expanded in vitro,
maintained in an undifferentiated state and retain the capacity to
differentiate into neurons, astrocytes and oligodendrocytes [1,2,3].
Previous in vitro studies, however, showed that when neural
progenitor cells were permitted to differentiate, they gave rise to
mainly glial cells and only smaller fraction developed into neurons
[4,5,6,7,8]. Although the culture systems used by various authors
have differed with regard to the species, anatomic location, and
developmental age of the harvested tissue, there is growing
evidence to suggest that the choice of lineage is determined, at
least in part, by environmental factors, among which neurotrophic
factors play a potential modulating role in differentiation of
progenitor cells [2,9,10]. For example, the exogenous addition of
ciliary neurotrophic factor (CNTF) and subsequent gp130-signal
activation promotes the differentiation of astrocytes from embry-
onic hippocampus, cortex and spinal cord derived progenitor cells
[11,12,13,14,15,16]. Brain-derived neurotrophic factor (BDNF)
induces neuronal differentiation from embryonic striatum, subep-
endymal zone and hippocampus derived progenitor cells
[4,9,17,18]. Neurotrophin-3 (NT-3) induces neuronal differentia-
tion from embryonic cortex and hippocampus derived progenitor
cells [18,19]. Despite these extensive studies using the exogenous
application of neurotrophic factors, little is known about the effect
of endogenous neurotrophic factors on the differentiation of
progenitor cells. We suggest that differentiation of neural
progenitor cells is regulated not only by exogenous level of growth
factors but rather, the endogenous expression of growth factors also
play crucial roles in the differentiation of neural progenitor cells.
In this study, we sought to determine the extent to which
differentiation of spinal progenitor cells is altered by manipulation
of endogenous as well as exogenous neurotrophic factors in vitro. We
focused on the spinal progenitor cells because spinal progenitor
cells may be distinct from cortical progenitor cells [20]. A better
understanding of the control mechanism of spinal progenitor cell’s
fate should enhance efforts to develop effective transplantation
strategies aimed at restoring functional connectivity in the injured
spinal cord.
PLoS ONE | www.plosone.org 1 June 2011 | Volume 6 | Issue 6 | e20717In the present study, we used ribonuclease (RNase) protection
assay to detect the expression of multiple neurotrophic factors
genes in both developing spinal cord and embryonic spinal cord
derived-progenitor cells. We used triple epitope immunocyto-
chemistry to determine the phenotypic fate of progenitor cells in
vitro under different treatments, including neutralization of
endogenous CNTF and/or administration of exogenous BDNF
or NT-3. The data indicate that endogenous CNTF and exogenous
BDNF and NT-3 play crucial roles in the differentiation of E14
spinal cord derived- progenitor cells into astrocytes, neurons and
oligodendrocytes, respectively.
Results
Neurotrophic factor gene profile of spinal cord during
normal development
The development and maturation of progenitor cells depend
not only on their genetic programming, but also on sequences and
contributions of various environmental signals such as neuro-
trophic factors that are appropriate to their developmental stages.
How neurotrophic factors precisely control cell fate and
orchestrate the generation of neurons, astrocytes and oligoden-
drocytes in vivo is not clearly understood. To determine how
neurotrophic factor gene expression is regulated in the spinal cord
during normal development, we examined the neurotrophic factor
gene expression profiles of developing spinal cord between E14
and P17 by RNase protection assay.
A high level of NT-3 gene expression, a moderate level of
CNTF and a low level of BDNF were observed in E14 spinal cord,
but the bands for NGF, GDNF or NT-4 were undetectable
(Fig. 1A). These neurotrophic factors showed distinct temporal
patterns of their gene expression during embryonic and postnatal
development. The high level of NT-3 gene expression at E14
decreased sharply by birth and subsequently there was almost no
expression of NT-3 at P17 (Fig. 1D). BDNF gene expression,
which was low at E14, increased between E19 and P10 (Fig. 1C).
Following the increase of BDNF gene expression, NGF and
GDNF gene expression increased (Fig. 1B, F). The temporal
pattern of NGF and GDNF gene expression was similar to that of
BDNF, but the magnitude of increase of NGF and GDNF gene
expression was less than that of BDNF. Levels of NGF, BDNF and
GDNF gene expression decreased simultaneously between P10
and P17. Consistent with this decrease of BDNF, GDNF and NGF
gene expression, CNTF gene expression increased significantly at
P17 (Fig. 1G).
Neurotrophic factor gene profiles of spinal progenitor
cells during differentiation
Progenitor cells were isolated from E14 rat spinal cord and
mechanically dissociated in culture medium. These cells expanded
to form ‘‘neurospheres’’ in the presence of EGF/FGF2 and over
95% of these cells were nestin-immunoreactive (Fig. 2A, B). BrdU-
labeling of these clusters confirmed that about 90% of the cells
proliferated as determined by nuclear BrdU corporation (Fig. 2C).
At 7 div, these neurospheres were centrifuged and dissociated
mechanically. Single cells were subsequently re-seeded into EGF/
FGF2-containing medium. This procedure resulted in a second
generation of neurospheres. After 2–4 passages, these cells were
seeded into the PEI-coated flasks or coverslips with differentiation
medium (EGF/FGF2-free and 1%FBS) following dissociation. At
1 div over 90% of these cells were still nestin immunoreactive
(Fig. 2D, E) and there were also trkB and/or CNTFRa
immunoreactive (Fig 2F, G). In the differentiation medium, these
cells slowed or stopped dividing. At 7 div about 30% of these cells
were labeled with BrdU during differentiation (Fig. 2H), and about
80% of these cells differentiated into neurons, astrocytes or
oligodendrocytes (Fig. 2I, J, K ). Quantitative analysis revealed that
majority of differentiated cells was astrocytes (52%), while fewer
cells differentiated into oligodendrocytes (23%) and neurons (4%).
This suggests that conditioning of the medium by the differenti-
ating progenitor cells, especially endogenous neurotrophic factors
may enhance glial cell differentiation.
To determine how neurotrophic factor gene expression is
regulated during the differentiation of E14 spinal cord derived
progenitor cells, we examined the neurotrophic factor gene
expression profiles of these cells by multi-probe RNase protection
assay. BDNF and CNTF gene expression were observed in spinal
progenitor cells before differentiation (0 div) (Fig. 3). During their
differentiation BDNF gene expression declined and then became
undetectable at 7 div. In contrast, CNTF gene expression
increased significantly at 3 div and by 7 div reached the levels 3-
fold greater than that of before differentiation (0 div). The
expression of NGF, NT-3, NT-4 or GDNF mRNA was
undetectable at any time point examined. Thus, E14 spinal cord
derived progenitor cells showed a different pattern of neurotrophic
factor gene expression during differentiation compared to the
normal embryonic developing spinal cord (Fig. 1), including up-
regulation of CNTF gene expression, down-regulation of BDNF
gene expression and a lack of NT-3 gene expression. Interestingly,
this pattern of neurotrophic factor gene expression is similar to
that observed during postnatal development, and correlated
temporally to active gliogenesis. Furthermore, spinal progenitor
cells expressed CNTFR-immunoreactivity during differentiation.
Taken together, these findings have led us to propose that CNTF
acts as an autocrine and/or paracrine signal involved in the
astrocytic differentiation from spinal progenitor cells.
Neutralization of endogenous CNTF inhibited the
astrocytic differentiation of spinal progenitor cells
To examine the role of endogenous CNTF in differentiation of
spinal progenitor cells, we studied the effect of neutralization of
endogenous CNTF on the fate of differentiating spinal progenitor
cells. Different concentrations (0–500 mg/ml) of anti-CNTF
antibody were applied to the differentiation medium at the time
of plating. Neutralization of endogenous CNTF by polyclonal
antibody (100 mg/ml and more) significantly decreased the
number of astrocytes to approximately 20% of the total number
of cells compared to 52% in control conditions (100 mg/ml normal
rat IgG) (Fig. 4C, D). In contrast, neutralization of endogenous
CNTF did not change the number of neurons or oligodendrocytes
(Fig. 4A, B, E, F). There are two possible explanations for these
findings. One is that neutralization of endogenous CNTF had an
effect on the survival or proliferation of progenitor cells.
Alternatively, neutralization of CNTF inhibited the differentiation
of progenitor cells into astrocytes.
Neutralization of endogenous CNTF did not affect the
survival or proliferation of spinal progenitor cells
To determine the effect of neutralization of endogenous CNTF
on survival and proliferation of spinal progenitor cells, we
examined the number of total cells and the percentage of nestin-
positive or BrdU-positive cell number to the total cell number.
Since the application of 100 mg/ml anti-CNTF antibody signifi-
cantly decreased the number of astrocytes as mentioned above, the
subsequent experiments were performed for neutralization of
endogenous CNTF using administration of 100 mg/ml anti-CNTF
antibody. There was no significant difference in the total cell
Spinal Progenitors and Endogenous Neurotrophin
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(Fig. 5A). Moreover, there were no significant differences in the
percentages of BrdU-positive cells between control and neutral-
ization groups at 7 div (Fig. 5B). In contrast, the percentage of
nestin-positive cells of the neutralization group was significantly
higher than that of control group at 7 div (p,0.05) (Fig. 5C). These
findings suggest that neutralization of endogenous CNTF did not
influence the survival or proliferation of the progenitor cells, but
rather inhibited the astrocytic differentiation of these cells,
resulting in the increase of the number of nestin-positive
progenitor cells.
Neutralization of endogenous CNTF and administration
of exogenous BDNF/NT-3 promote the differentiation
into neurons/oligodendrocytes
Neutralization of endogenous CNTF inhibited the differentia-
tion of progenitor cells into astrocytes, but did not affect the
differentiation into neurons or oligodendrocytes, resulting in the
increase of the undifferentiated progenitor cells. These progenitor
cells may require additional environmental cues for their
differentiation into neurons or oligodendrocytes. Spinal progenitor
cells show two major differences in their neurotrophic factor gene
expression profile during their differentiation compared to that of
the normal spinal cord during embryonic development: 1) there is
a down-regulation of endogenous BDNF gene expression and
2) there is a lack of endogenous NT-3 gene expression in the spinal
progenitor cells. In order to mimic the neurotrophic factor profile
of spinal cord during embryonic development, we applied
exogenous BDNF or NT-3 to culture cells in combination with
anti-CNTF polyclonal antibody.
The administration of exogenous BDNF alone increased the
number of neurons, but did not change the number of either
astrocytes or oligodendrocytes (Fig. 6A, D, G). The administration
of exogenous NT-3 alone increased the number of oligodendro-
cytes, but did not change the number of either neurons or
astrocytes (Fig. 6A, D, G). However, the administration of
exogenous BDNF or NT-3 did not have any apparent effect on
the survival or proliferation of spinal progenitor cells (data not
shown). In combination with anti-CNTF antibody, the adminis-
tration of exogenous BDNF not only decreased the number of
astrocytes (Fig. 6D, E) but also increased the number of neurons
(Fig. 6A, B). There was, however, no significant change in the
number of oligodendrocytes (Fig. 6G, H). In combination with
anti-CNTF antibody, the administration of exogenous NT-3 not
Figure 1. Neurotrophic factor gene profile of spinal cord during development. Spinal cord tissues were harvested from embryos or
neonates at each developmental age. Total RNA (10 mg) was loaded at each lane for RNase protection assay (A). There were three different temporal
patterns of neurotrophic factor gene expression. NT-3 gene expression peaked at E14 and then declined sharply (D). BDNF gene expression (C),
followed by NGF (B) and GDNF (F), increased between E19 and P10. Initial moderate expression of CNTF increased significantly at P10 and P17 (G).
Each value represented mean 6 SEM of % GAPDH obtained from four independent experiments. GAPDH was used as an internal control to normalize
for loading differences. * Significant difference compared to the other developmental ages except (*), # Significant difference compared to the other
developmental ages including (*) (p,0.05, Tukey post hoc test).
doi:10.1371/journal.pone.0020717.g001
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increased the number of oligodendrocytes (Fig. 6G, I). This
treatment did not affect the number of neurons (Fig. 6A, C). There
was a significant increase in the number of oligodendrocytes in the
cultures treated by NT-3 plus anti-CNTF antibody compared to
NT-3 alone (Fig. 6G).
Discussion
Multipotent and self-renewing progenitor cells that generate
neurons and macroglia are found in most areas of the developing
nervous system [1]. Using a neurosphere culture system that allows
us to follow the enriched expansion of spinal neural progenitor
cells [5,21], we examined their fate when exposed to conditions
that mimic the environment of late embryonic spinal cord in terms
of neurotrophic factor profile: neutralization of endogenous CNTF
and administration of exogenous BDNF or NT-3. Our results
indicate that endogenous CNTF plays a role in differentiation of
spinal progenitor cells into astrocytes. Furthermore, the additional
administration of exogenous BDNF or NT-3 promotes their
differentiation into neurons or oligodendrocytes, respectively.
Neurotrophic factor profile of spinal progenitor cells
during differentiation is similar to that of spinal cord
during postnatal development
Under baseline culture conditions approximately 50% of E14
spinal cord-derived progenitor cells differentiated into astrocytes.
This differentiation of spinal progenitor cells towards an astrocytic
phenotype may reflect autocrine and/or paracrine interactions
between these cells. Such an autocrine mechanism of neurotrophic
factor (NT-3 and BDNF) appears to regulate neurogenesis in
progenitor cells isolated from the E14 mouse cortex [19,22]. Thus,
endogenous neurotrophic factors may play a role in regulating the
differentiation of spinal progenitor cells as well [9]. To the best of
our knowledge, this is the first demonstration that spinal
progenitor cells express a distinct profile of endogenous neurotrophic
factor gene expression during their differentiation. We demon-
strated that before differentiation, spinal progenitor cells expressed
prominent CNTF and BDNF mRNAs in vitro. During their
differentiation, endogenous BDNF gene expression significantly
decreased, whereas CNTF gene expression significantly increased.
This pattern of neurotrophic factor gene expression of spinal
progenitor cells in vitro is similar to that of the spinal cord during
postnatal development correlated with active gliogenesis, but
different from that of the spinal cord during embryonic
development correlated with neurogenesis.
In fact, we demonstrated the increase of NGF, BDNF and
GDNF gene expression within the developmental spinal cord,
which corresponds temporally with the period of differentiation
and maturation of neurons [23–24], and also the simultaneous
down-regulation of NGF, BDNF and GDNF gene expression and
up-regulation of CNTF gene expression, which are coincident
with postnatal gliogenesis [24,25].
Mimicking of the neurotrophic factor profile of spinal
cord during embryonic development inhibits the
differentiation of spinal progenitor cells into astrocytes,
and promotes the differentiation into neurons and
oligodendrocytes
Spinal progenitor cells were prepared from E14 embryos, a time
when active neurogenesis occurs [23,24]. Neurotrophic factor
gene expression of spinal progenitor cells in vitro differed from that
of the embryonic spinal cord during normal development in vivo.
The spinal progenitor cells had higher levels of CNTF, and lower
Figure 2. Characterization of E14 spinal cord-derived progenitor cells. Progenitor cells obtained from E14 fetal spinal cord formed sphere in
the growth medium containing EGF/FGF2 (A: phase contrast image) and they were nestin (B: identical field to A) and BrdU immunoreactive (C). After
dissociation, these cells were seeded on PEI-coated coverslips in no EGF/FGF2 and 1%FBS containing culture medium (D: phase contrast image). At
1div, over 90% of the dissociated progenitor cells were still nestin immunoreactive (E: identical field to D) and there were also trkB (F) and/or CNTFRa
immunoreactive (G). These cells slowed or stopped dividing and during differentiation about 30% of the cells were labeled with BrdU at 7 div (H). At 7
div, these cells were triple-stained with anti-TuJ1 for neuron (I), GFAP for astrocyte (J) and O4 for oligodendrocyte (K). Approximately 50% of these
cells differentiated into astrocytes.
doi:10.1371/journal.pone.0020717.g002
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suggest that these differences in the balance of neurotrophic factors
environment may promote the differentiation of spinal progenitor
cells in vitro into astrocytes. We hypothesize that by altering the
neurotrophic factor profile that neural progenitor cells are exposed
to in vitro to mimic that of the embryonic spinal cord in situ would
inhibit astrocytic differentiation and promote neural differentiation
of the spinal progenitor cells.
First, we showed that neutralization of endogenous CNTF
inhibited the differentiation of spinal progenitor cells into
astrocytes, resulting in the increase of the number of undifferen-
tiated progenitor cells that were nestin-positive. Neutralization of
endogenous CNTF did not affect the survival or proliferation of
spinal progenitor cells. Consistently, previous studies have
demonstrated that administration of exogenous CNTF stimulates
the two signal-transducing subunits of the CNTFRa-leukemia
inhibitory factor receptor b (LIFRb) and gp130 and induces the
differentiation of progenitor cells into astrocytes [11,15], and that
there was a significant reduction in the numbers of neurons and
astrocytes within the central nervous system of CNTFRa [26],
LIFRb [27] or gp130 [14] knockout mice. In contrast to mice
lacking CNTFRa, LIFRb or gp130, mice lacking CNTF
developed in a normal manner and displayed only mild motor
neuron problems later in adulthood without any major neurolog-
ical abnormalities [28]. Because there is a redundancy of CNTF
related neurotrophic factors such as LIF, IL-6 and Oncostatin M
in vivo, it is difficult to determine the function of endogenous
CNTF by these knockout mice studies. Our in vitro data indicate
that endogenous CNTF plays a role in inducing the differentiation of
spinal progenitor cells into astrocytes, but does not effect their
survival or proliferation. A possible explanation of this discrepancy
between previous knockout mice studies and our in vitro study is
that the redundancy of neurotrophic factors in vivo was not
apparent in our cultures because these progenitor cells became
more homogenous, at least morphologically, after 2-4 passages.
Although CNTF was previously shown to promote survival of
several kinds of neurons such as motor neurons [29,30],
hippocampal neurons [31] and sensory neurons [32] and also
survival and maturation of oligodendrocytes [33,34], neutraliza-
tion of endogenous CNTF did not affect the number of neurons or
oligodendrocytes in our cultures. Nakashima et al. demonstrated
that in gp130 knockout mice there was a significant neuronal loss
at E18.5, but not at E14.5[14]. Their findings suggest that
signaling through gp130 is essential for survival of subgroups of
differentiated neurons and that this effect depends on the
developmental stage of neurons. In our short-term culture system,
at least, neutralization of endogenous CNTF did not have
apparent effects either on the differentiation of spinal progenitor
cells into neurons or oligodendrocytes or on their survival. Further
studies using long-term culture system will be needed to determine
whether there are any effects of neutralization of endogenous
CNTF on their long-term survival and maturation.
Figure 3. Neurotrophic factor gene profile of E14 spinal cord derived-progenitor cells during differentiation in vitro. After 2–4
passages, cells were seeded on the PEI-coated culture flasks at a density of 2610
5 cells/ml in the differentiation medium (no EGF/FGF2, 1% FBS).
Culture cells were harvested at 1, 3 and 7 days in vitro (div). As a control cells were harvested immediately after dissociation (0 div). Total RNA (5 mg)
was loaded at each lane for RNase protection assay. Before differentiation (0 div), there were two prominent gene expression of BDNF and CNTF.
While BDNF gene expression decreased significantly at 3 and 7 div, CNTF gene expression increased significantly at 3 and 7 div. Each value
represented mean 6 SEM of % GAPDH obtained from three independent experiments. GAPDH was used as an internal control to normalize for
loading differences. * Significant difference compared to 0 div (p,0.05, Tukey post hoc test).
doi:10.1371/journal.pone.0020717.g003
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the differentiation of spinal progenitor cells into astrocytes, this led
to an increase in the number of undifferentiated progenitor cells,
rather than differentiation into the other cellular phenotypes. This
suggests that these cells need additional environmental cues to
promote the differentiation of spinal progenitor cells into neurons
or oligodendrocytes. Second, we showed that administration of
exogenous BDNF or NT-3 combined with neutralization of
endogenous CNTF not only decreased the number of astrocytes,
but also increased the number of neurons or oligodendrocytes,
respectively. Previously BDNF and NT-3 were shown to promote
neuronal differentiation of progenitor cells isolated from E14
striata [4], E14 cortex [19] and E16 hippocampus [18], and
CNTF were shown to promote the astrocytic differentiation from
NSCs in collaboration with Notch signals [35]. We also
demonstrated that treatment of BDNF alone promoted the
neuronal differentiation of spinal progenitor cells, but did not
affect the glial differentiation. Treatments of BDNF plus anti-
CNTF antibody promoted neuronal differentiation and also
inhibited the astrocytic differentiation. There was no significant
difference in the number of neurons between the cultures treated
by BDNF plus anti-CNTF antibody and BDNF alone. Treatment
of NT-3 alone promoted the differentiation of spinal progenitor
cells into oligodendrocytes, but not into neurons. Treatment of
NT-3 plus anti-CNTF antibody promoted the differentiation into
oligodendrocytes and inhibited the astrocytic differentiation.
Furthermore, there was a significant difference in the number of
oligodendrocytes between the cultures treated by NT-3 plus anti-
CNTF antibody and NT-3 alone. Rao and colleagues demon-
strated that there are heterogeneous populations of E13.5 spinal
cord derived progenitor cells including multipotent, neuronal- and
glial- restricted progenitor cells [16,36]. Jean and colleagues
reported that in the chemical demyelination model of rat CNS,
treatment of NT-3 increased mature oligodendrocyte population
and influenced directly on the oligodendrocyte lineage cells to
enhance remyelination [37]. A possible explanation of our findings
is that neutralization of endogenous CNTF inhibits the differen-
tiation of multipotent and/or glial- restricted progenitor cells into
astrocytes, and that they differentiate into oligodendrocytes in the
presence of NT-3 and into neurons in the presence of BDNF.
Previous studies demonstrated that there were also endogenous
neural stem/progenitor cells in adult spinal cord [21,38,39], but
after injury these endogenous stem/progenitor cell proliferated
[40], migrated to the lesion site and differentiated into astrocytes
Figure 4. Neutralization of endogenous CNTF inhibited the differentiation of spinal progenitor cells into astrocytes. After 2–4
passages, cells were seeded on PEI-coated coverslips at a density of 2610
5 cells/ml in the differentiation medium with different concentrations of
anti-CNTF antibody (0–500 mg/ml). At 7div the culture cells were triple-stained with TuJ1 (A), GFAP (C) and O4 (E). Neutralization of endogenous CNTF
by polyclonal antibody (100 mg/ml and more) significantly decreased the number of astrocytes (D), but did not affect the numbers of neurons (B) or
oligodendrocytes (F). * Significant difference compared to the control (p,0.05, Tukey post hoc test).
doi:10.1371/journal.pone.0020717.g004
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glial scar formation after spinal cord injury. CNTF gene
expression increased significantly, but BDNF and NT-3 gene
expression does not increase after spinal cord injury in the adult
[42,43]. This notion is strongly supported by the previous study
[44] showing that transplantation of fibroblasts producing BDNF
or NT-3 into contused spinal cord promoted the differentiation of
endogenous progenitor cells into oligodendrocytes. It was
noteworthy that the blocking of CNTF at the beginning of SCI
provides a more favorable environment for the differentiation of
transplanted NSC and the regeneration of host axons, thereby
promoting the functional recovery after SCI [45]. This strategy
could be applied to cell transplantation of ES- and iPS-cell derived
NSC for SCI.
Materials and Methods
Developmental study
Thoracic spinal cord tissues were harvested from Sprague-
Dawley rats (Zivic Laboratories, Zelienople, PA) at Embryonic
Days 14 (E14) and E19 and Postnatal days 3 (P3), P7 and P17.
Following perfusion with ice-cold saline, tissue was frozen on dry-
ice quickly and stored at 280 uC until ribonuclease protection
assay.
Spinal Progenitor Cell Culture and Passage
Progenitor cells were cultured using the procedures of Weiss
et al (1996b). Thoracic spinal cord tissues were removed from E14
embryos and mechanically dissociated with a fire-polished pipette
in culture medium composed of a 1:1 mixture of DMEM and F-12
nutrient plus 50 U/ml penicillin and 50 mg/ml streptomycin (Life
Technologies, Rockville, MD). After dissociation, cells were seeded
in culture flasks (Nunclon) at a concentration of 2610
5 cells/ml
with growth medium. The growth medium contained DMEM and
F-12 nutrient (1:1), 50 U/ml penicillin, 50 mg/ml streptomycin,
0.6% glucose, 2 mM glutamine, 3 mM sodium bicarbonate,
5 mM HEPES buffer, 25 mg/ml insulin, 100 mg/ml transferrin
(Life Technologies), 20 nM progesterone, 60 mM putrescine,
30 nM selenium chloride (Sigma, St Louis, MO), and 20 ng/ml
EGF and FGF2 (Pepro Tech, Rocky Hill, NJ). After 7 days in vitro
(div), cells formed well-developed floating clusters (spheres). To
passage spheres, we pelleted 7 div spheres after centrifugation at
4006g for 5 min, resuspended them in fresh medium, and
mechanically dissociated them with a fire-polished Pasteur pipette.
Single cells were seeded into growth medium in culture flasks at a
concentration of 2610
5 cells/ml. This procedure resulted in a
second generation of spheres.
Treatments of Cultures
After 2–4 passages, neurospheres were centrifuged and
dissociated in EGF/FGF2-free medium. Cells were plated on
the polyethyleneimine (PEI)-coated flasks at a density of
2610
5 cells/ml in EGF/FGF2-free and 1% fetal bovine serum
(FBS) culture medium (differentiation medium). The culture flasks
were coated by 0.1% PEI (sodium tetraborate decahyrate 0.15 M,
pH 8.5) overnight at room temperature. At 1, 3 and 7 div, these
cells were harvested for RNase protection assays of neurotrophic
factor gene expression profiles. As a control, cells were also
harvested before differentiation following dissociation (0 div).
For immunocytochemistry, after 2–4 passages neurospheres
were centrifuged and dissociated in EGF/FGF2-free medium.
Cells were plated onto PEI-coated 12 mm coverslips (Fisher
Scientific, Pittsburgh, PA) in 24-well plates at a density of
2610
5 cells/ml with 1 ml differentiation medium. The role of
Figure 5. Effect of neutralization of endogenous CNTF on the
survival and proliferation of spinal progenitor cells. Compari-
sons of total cell number (A) and the percentage of BrdU (B) and nestin
(C) positive cells to total cell number between control and neutraliza-
tion groups (anti-CNTF antibody, 100 mg/ml). Neutralization of endog-
enous CNTF did not affect the survival or proliferation of spinal
progenitor cells, but increased the number of undifferentiated
progenitor cells expressing nestin (C). * Significant difference between
two groups (p,0.05, Mann-Whitney U-test).
doi:10.1371/journal.pone.0020717.g005
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by neutralizing the endogenous CNTF with polyclonal antibody
against CNTF IgG. Rat anti-CNTF antibody (Sigma) was applied
to the differentiation medium at various concentrations (0–
500 mg/ml) at the time of plating. In the control group, we added
normal rat IgG (100 mg/ml, Sigma) to the differentiation medium.
For analysis of the potential effects of exogenous BDNF or NT-3
on the differentiation of spinal progenitor cells, BDNF or NT-3
(20 ng/ml each, gift from Regeneron Pharmaceuticals, Inc.) was
added to the medium at the time of plating and added every 2–3
days. At 7 div, these cultured cells were processed for
immunocytochemistry.
RNase protection assay
Total RNA from each sample was extracted using TRIzol
Reagent (Life Technologies) according to the supplier’s instruc-
tions. RNase protection assays for relative quantification of
neurotrophic factor mRNAs [nerve growth factor (NGF), BDNF,
NT-3, NT-4, glial-derived neurotrophic factor (GDNF), CNTF]
were performed according to the supplier’s instructions (PharMin-
gen, San Diego, CA). Briefly, a rat neurotrophin template set
(45028P, PharMingen) was labeled with (a-
32P) uridine triphos-
phate. 4.6610
5 cpm of labeled probe and 5 mg total RNA were
used for hybridization. After RNase treatments, the protected
probes were resolved on a 5% urea-polyacrylamide gel. Autora-
diographs were produced by exposing the labeled gels to Biomax
film (Kodak, Rochester, NY) with intensifying screens at 280uC.
The gels were exposed to a phosphor screen and analyzed using a
phosphoimaging system for quantification (Molecular Dynamics,
Sunnyvale, CA). GAPDH was used as an internal control to
normalize for loading differences.
Antibodies
Primary antibodies for indirect immunocytochemistry included
a mouse monoclonal antibody to TuJ1 (BAbCO, West Grove,
PA), rabbit antiserum to glial fibrillary acidic protein (GFAP,
Dako, Carpinteria, CA), mouse-monoclonal antibody to O4
(Boeringer Mannheim, Indianapolis, IL), mouse anti-nestin
monoclonal antibody (Chemicon, Temecula, CA), antibodies for
trkB and CNTF receptor a (CNTFRa, Santa Cruz, Santa Cruz,
Figure 6. Effects of additional application of exogenous neurotrophic factors on the differentiation of spinal progenitor cells.
Treatments of cultures were as follows in each bar graph: (1) control (normal rat IgG 100 mg/ml); (2) BDNF (20 ng/ml); (3) NT-3 (20 ng/ml); (4) anti-
CNTF (100 mg/ml); (5) anti-CNTF +BDNF; (6) anti-CNTF + NT-3. At 7 div after each treatment, cells were triple-stained with TuJ1 for neuron, GFAP for
astrocyte and O4 for oligodendrocyte. Combined treatments of anti-CNTF plus exogenous BDNF (B, E, H) or NT-3 (C, F, I) not only inhibited the
astrocytic differentiation (lanes 5 and 6 in D, E, F), but also promoted the differentiation of spinal progenitor cells into neurons (lane 5 in A, B) or
oligodendrocytes (lane 6 in G, I), respectively. The application of exogenous BDNF alone (lane 2 in A) or NT-3 alone (lane 3 in G) also increased the
numbers of neuron or oligodendrocytes, respectively. However, the differentiation of progenitor cells into astrocytes was not inhibited by these
treatments (lanes 2 and 3 in D). Compared to the cultures treated by NT-3 alone (lane 3 in G), there was a significant increase in the number of
oligodendrocytes in the cultures treated by anti-CNTF plus NT-3 (lane 6 in G). * Significant difference compared to the control (lane 1 in A, D, G)
(p,0.05, Tukey post hoc test). # Significant difference compared to NT-3 alone (lane 3 in G) (p,0.05, Tukey post hoc test).
doi:10.1371/journal.pone.0020717.g006
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Jackson ImmunoResearch (West Grove, PA).
Immunocytochemistry
Immunocytochemical procedures were performed on spinal
progenitor cells at 7 div using a slight modification of the
procedures of Weiss et al (1996b).
In brief, these cells were fixed with 4% paraformaldehyde for
20 min and washed three times successively with phosphate
buffered saline (PBS, pH 7.4). For triple labeling of TuJ1, GFAP
and O4, cells were incubated with the primary antibodies for TuJ1
and GFAP diluted in PBS containing 5% normal goat serum and
0.01% Triton-X100 at the same time at 4uC overnight. After
washing, cells were incubated with the secondary antibodies of
TRITC-conjugated anti-mouse IgG and Cy5-conjugated anti-
rabbit IgG at 37uC for 30 min. After washing, cells were incubated
with the primary antibody for O4 diluted in PBS containing 5%
normal goat serum and 0.01% Triton-X100 at 37uC for 2 hr.
After washing, cells were incubated with the secondary antibody of
FITC-conjugated anti-mouse IgM at 37uC for 30 min. After
washing, the cells were mounted with Fluorsave (Calbiochem, La
Jolla, CA). The numbers of immuno-reactive cells and total cells
per each field were counted over 206 fields (four coverslips, six
random fields per each coverslip) after capturing each image by a
confocal laser-scanning microscope (Fluoview, Olympus, Melville,
NY). Each immunoreactive cell was counted only when the
nucleus was detectable on the 206field investigated.
Proliferation Assay
To determine the effect of neutralization of endogenous CNTF
on the proliferation of progenitor cells, BrdU labeling of dividing
cells was performed as described previously by Ahmed et al.
(1995). BrdU (1 mM; Sigma) was added to each of the wells
containing progenitor cells (2610
5 cells/ml) in 1 ml differentiation
medium with or without anti-CNTF antibody (100 mg/ml) at the
time of plating for 7 div. The presence of BrdU did not modify
total cell number. Cells were stained with ZYMED BrdU staining
kit (Zymed, South San Francisco, CA) and counter stained with
hematoxylin according to the supplier’s instructions. The percent-
ages of BrdU positive cells to total cells of the examined field (four
coverslips, six random fields per each coverslip) were calculated.
Statistics
Each value of RNase protection assays represented mean 6
SEM of percentage of each neurotrophic factor mRNA expression
to GAPDH obtained from three independent experiments.
Statistical comparisons were made using one-way ANOVA with
a Tukey post hoc test on each neurotrophic factor among different
time points. Each value of quantitative analysis of the immuno-
cytochemistry represented mean 6 SEM of percentage of
immunopositive cell number to total cell number obtained from
three independent experiments. Statistical comparisons were made
using one-way ANOVA with a Tukey post hoc test or Mann-
Whitney U-test among different treatment groups. Statistical
significance was set at p,0.05.
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